Holen Sie sich die Stockscreener-App
1.03
14.44%
0.13
Schlusskurs vom Vortag:
$0.90
Offen:
$0.9
24-Stunden-Volumen:
440.65K
Relative Volume:
1.74
Marktkapitalisierung:
$51.31M
Einnahmen:
$2.82M
Nettoeinkommen (Verlust:
$-13.47M
KGV:
-1.5147
EPS:
-0.68
Netto-Cashflow:
$-13.61M
1W Leistung:
+46.10%
1M Leistung:
+56.06%
6M Leistung:
-0.96%
1J Leistung:
+19.08%
1-Tages-Spanne:
$0.8502
$1.04
1-Wochen-Bereich:
$0.7099
$1.04
52-Wochen-Spanne:
$0.3954
$1.39
Neuroone Medical Technologies Corp Stock (NMTC) Company Profile
Firmenname
Neuroone Medical Technologies Corp
Sektor
Branche
Telefon
(952) 426-1383
Adresse
7599 ANAGRAM DR, EDEN PRAIRIE
Vergleichen Sie NMTC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| 0.99 | 0 | 0 | 0 | 0 | 0.00 | |
GOODO
Gladstone Commercial Corporation
|
20.31 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.7364 | 130.22M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.1496 | 346.50M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.24 | 0 | 0 | 0 | 0 | 0.00 |
|
DWLD
Davis Select Worldwide ETF
|
42.12 | 0 | 0 | 0 | 0 | 0.00 |
Neuroone Medical Technologies Corp Stock (NMTC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-05 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2022-03-29 | Herabstufung | Craig Hallum | Buy → Hold |
Neuroone Medical Technologies Corp Aktie (NMTC) Neueste Nachrichten
What analysts say about NeuroOne Medical Technologies Corporation stockOverwhelming profit margins - Autocar Professional
Is NeuroOne Medical Technologies Corporation a good long term investmentBreakout profit opportunities - jammulinksnews.com
NeuroOne Medical Technologies Corporation Stock Analysis and ForecastAccelerated investment success - jammulinksnews.com
81,000 Shares in NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Bought by Cambridge Investment Research Advisors Inc. - Defense World
Why NeuroOne Medical Technologies Corporation stock attracts strong analyst attentionBreakout Momentum Stocks - Newser
What makes NeuroOne Medical Technologies Corporation stock price move sharplySmart Money Trade Setups - Newser
How NeuroOne Medical Technologies Corporation stock performs during market volatilityHigh Return Intraday Picks - Newser
Revolutionary OneRF Treatment Transforms Patient's Life: From 10 Daily Seizures to Complete Freedom for 1 Year - Stock Titan
Certain Warrants of NeuroOne Medical Technologies Corporation are subject to a Lock-Up Agreement Ending on 19-JUN-2025. - MarketScreener
Certain Common Stock of NeuroOne Medical Technologies Corporation are subject to a Lock-Up Agreement Ending on 19-JUN-2025. - MarketScreener
Jane Street Group LLC Takes $33,000 Position in NeuroOne Medical Technologies Co. (NASDAQ:NMTC) - Defense World
NeuroOne Medical (NMTC) Enhances Leadership with New General Cou - GuruFocus
NeuroOne Cuts Legal Costs with Strategic General Counsel Hire: Former Partner Joins Executive Team - Stock Titan
NeuroOne CEO to Meet Investors at MedInvest Conference: Spotlight on Neural Surgery Innovation - Stock Titan
NeuroOne Medical Technologies (NASDAQ:NMTC) Trading 1.1% Higher – Should You Buy? - Defense World
NeuroOne Completes FDA Submission for OneRF Trigeminal Nerve Ablation System - Medical Product Outsourcing
NeuroOne Medical Technologies Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
NMTC Achieves Growth in Q2 with Advancements in OneRF Technology - GuruFocus
Earnings call transcript: NeuroOne Medical beats EPS expectations in Q1 2025 - Investing.com Canada
NeuroOne Medical Technologies Corp (NMTC) Q2 2025 Earnings Call Highlights: Revenue Surge and ... - Yahoo Finance
NeuroOne Medical Technologies Corp (NMTC) Q2 2025 Earnings Call - GuruFocus
NeuroOne Medical Technologies Corp Reports Q2 FY2025 Earnings: E - GuruFocus
NEUROONE MEDICAL TECHNOLOGIES Corp SEC 10-Q Report - TradingView
NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6% - Stock Titan
NeuroOne Medical (NMTC) Welcomes New Chief Medical Advisor | NMT - GuruFocus
NeuroOne Medical Technologies (NMTC) Appoints New Chief Medical Advisor - GuruFocus
NeuroOne appoints Dr. Patil as Chief Medical Advisor - Investing.com
NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor - Stock Titan
NeuroOne Medical Opens Exclusive Investor Access: CFO Hosts One-on-One Meetings at Plaza Hotel - Stock Titan
NeuroOne Medical Announces Participation in The D. Boral Capital Inaugural Global Conference - The Kingston Whig Standard
NeuroOne Medical Tech (NMTC) Coverage Initiated by Ladenburg Tha - GuruFocus
This Okta Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Geode Capital Management LLC Grows Stake in NeuroOne Medical Technologies Co. (NASDAQ:NMTC) - Defense World
NeuroOne Earnings: Medical Tech Leader to Reveal Q2 2025 Growth Strategy and Financial Results - Stock Titan
NeuroOne Medical Technologies Corp [NMTC] Records 50-Day SMA of $0.8911 - knoxdaily.com
NeuroOne Medical Technologies Corp’s results are impressive - uspostnews.com
The Future of NeuroOne Medical Technologies Corp: Analyzing NMTC - investchronicle.com
NeuroOne Medical (NMTC) Files Early FDA Submission for Trigemina - GuruFocus
NeuroOne Medical (NMTC) Files Early FDA Submission for Trigeminal Nerve Ablation | NMTC Stock News - GuruFocus
NeuroOne files early FDA 510(k) for nerve ablation system - Investing.com
NeuroOne's Revolutionary Facial Pain Treatment Advances: FDA Review Next for 95% Effective Device - Stock Titan
EXCLUSIVE: NeuroOne Submits FDA Marketing Application For OneRF Trigeminal Nerve Ablation System For Facial Pain - Benzinga
NeuroOne Medical Technologies Corp (NMTC) Q1 2025 Earnings Call Highlights: Regulatory Success ... - Yahoo Finance
NeuroOne Medical Technologies Corp (NMTC) Q1 2025 Earnings Call - GuruFocus
CTEK Expects Significant Revenue Growth by Fiscal Year 2025 | NMTC Stock News - GuruFocus
NeuroOne Medical (NMTC) Expands Partnership with Zimmer Biomet and Secures Funding | NMTC Stock News - GuruFocus
Neuroone Medical Technologies Corp -Company Now Fully Funded Through At Least Fiscal 2026 - marketscreener.com
NeuroOne secures funding through fiscal 2026, unaffected by tariffs - Investing.com
Finanzdaten der Neuroone Medical Technologies Corp-Aktie (NMTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.64%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):